Literature DB >> 1884211

Characterization of vanilloid receptors in the dorsal horn of pig spinal cord.

A Szallasi1, P M Blumberg.   

Abstract

Specific [3H]resiniferatoxin binding is thought to represent the postulated vanilloid (capsaicin) receptor. We have previously characterized [3H]resiniferatoxin binding to membranes from rat and pig dorsal root ganglia, which contain the cell bodies of capsaicin-sensitive primary afferent neurons. We now demonstrate specific binding of [3H]resiniferatoxin to particulate preparations from pig dorsal horn, which contains the central nerve endings of the capsaicin-sensitive primary afferent neurons. The Kd was 0.27 +/- 0.03 nM; the Bmax was 370 +/- 40 fmol/mg protein. Vanilloids of the capsaicin class (capsaicin, piperine, zingerone) and resiniferatoxin class (tinyatoxin, 12-deoxyphorbol 13-phenylacetate 20-homovanillate) inhibited binding with affinities consistent with their relative in vivo potencies. Given the interest in vanilloids as potential non-narcotic analgesic agents, this binding assay affords an attractive approach for characterization of structure-activity relations at spinal vanilloid receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1884211     DOI: 10.1016/0006-8993(91)90982-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  TRPV1: on the road to pain relief.

Authors:  Andrés Jara-Oseguera; Sidney A Simon; Tamara Rosenbaum
Journal:  Curr Mol Pharmacol       Date:  2008-11       Impact factor: 3.339

2.  Effects of piperine, the pungent component of black pepper, at the human vanilloid receptor (TRPV1).

Authors:  Fergal N McNamara; Andrew Randall; Martin J Gunthorpe
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

3.  Capsaicin modulates acetylcholine release at the myoneural junction.

Authors:  Baskaran Thyagarajan; Joseph G Potian; Padmamalini Baskaran; Joseph J McArdle
Journal:  Eur J Pharmacol       Date:  2014-10-23       Impact factor: 4.432

Review 4.  TRPV1 activation is not an all-or-none event: TRPV1 partial agonism/antagonism and its regulatory modulation.

Authors:  Peter M Blumberg; Larry V Pearce; Jeewoo Lee
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

Review 5.  Moving towards supraspinal TRPV1 receptors for chronic pain relief.

Authors:  Enza Palazzo; Livio Luongo; Vito de Novellis; Liberato Berrino; Francesco Rossi; Sabatino Maione
Journal:  Mol Pain       Date:  2010-10-11       Impact factor: 3.395

6.  Non-vanillyl resiniferatoxin analogues as potent and metabolically stable transient receptor potential vanilloid 1 agonists.

Authors:  Hyun-Kyung Choi; Sun Choi; Yoonji Lee; Dong Wook Kang; HyungChul Ryu; Han-Joo Maeng; Suk-Jae Chung; Vladimir A Pavlyukovets; Larry V Pearce; Attila Toth; Richard Tran; Yun Wang; Matthew A Morgan; Peter M Blumberg; Jeewoo Lee
Journal:  Bioorg Med Chem       Date:  2008-12-25       Impact factor: 3.641

7.  Inhibition of [3H]resiniferatoxin binding to rat dorsal root ganglion membranes as a novel approach in evaluating compounds with capsaicin-like activity.

Authors:  A Szallasi; J Szolcsanyi; Z Szallasi; P M Blumberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-11       Impact factor: 3.000

8.  TRPV1 Inhibits the Ventilatory Response to Hypoxia in Adult Rats, but Not the CO₂-Drive to Breathe.

Authors:  Luis Gustavo A Patrone; Jaime B Duarte; Kênia Cardoso Bícego; Alexandre A Steiner; Andrej A Romanovsky; Luciane H Gargaglioni
Journal:  Pharmaceuticals (Basel)       Date:  2019-01-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.